<DOC>
	<DOCNO>NCT00867412</DOCNO>
	<brief_summary>Patients possible operable non-small cell lung cancer randomise conventional staging , conventional staging PET/CT . According , patient operable tumor refer surgery , number thoracotomy futile thoracotomy wil compare two group order ass possible benefit PET/CT .</brief_summary>
	<brief_title>Randomized Study Positron Emission Tomography - Computed Tomography ( PET/CT ) Pre-Operative Staging Lung Cancer</brief_title>
	<detailed_description>Patients possible operable NSCLC stag CT randomise PET-CT FDG , prior mediastinoscopy . All patient refer mediastinoscopy unless positive FDG uptake result positive biopsy suggest stage IV disease . Biopsies perform accord follow criterion : 1 . Lymph node number accord Mountain classification , abnormal lesion must confirm histologically , mediastinoscopy thoracotomy . 2 . PET-positive lesion liver must biopsied unless ultrasound MRI unequivocally indicate lesion benign cyst haemangioma . 3 . PET-negative adrenal lesion accept without biopsy CT scan indicate lesion benign adenoma . 4 . PET-positive bone lesion must evaluate plain x-ray , CT , MRI , bone scintigraphy . In case equivocal finding biopsy must perform . 5 . PET-positive brain lesion must confirm CT MRI . Number patient : Patients clinically operable NSCLC CT-staging include . All patient must mediastinoscopy perform . All patient refer mediastinoscopy randomise informed consent . A total 430 consecutive , non-selected patient plan . It anticipate approximately 60 % refer patient clinical stage I-IIIa NSCLC undergo thoracotomy , risk type I II error 5 % 10 % , respectively , accept . Thus total 215 patient randomised arm order observe absolute difference 15 % number thoracotomy . This number seem sufficient evaluate difference secondary endpoint . After inclusion total 220 patient , correspond 110 PET-scans , interim analysis perform . In case highly significant difference number thoracotomy ( p &lt; 0,001 ) study close .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Clinically operable NSCLC CT 2 . Fit thoracotomy lobectomy pneumectomy lung function test 3 . CTscan thorax , include liver adrenal sign distant metastasis . 4 . No medical condition contraindication surgery . 5 . Age 1880 6 . No claustrophobia . 7 . Negative pregnancy test . 8 . No diabetes mellitus . 9 . Signed informed consent . 1 . Radiologically M1 disease . 2 . Pregnancy 3 . Known claustrophobia . 4 . Estimated FEV1 &lt; 30 % expect surgery . 5 . Diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>NSCLC</keyword>
	<keyword>PET/CT</keyword>
	<keyword>Surgery</keyword>
	<keyword>FDG</keyword>
	<keyword>stag</keyword>
</DOC>